Cara Therapeutics
CARA
$0.73
Share price
10.50%
Change (1 day)
-81.74%
Change (1 year)
Categories
Number of shares outstanding for Cara Therapeutics (CARA)
Number of shares outstanding as of April 2024 : 54,235,695
According to Cara Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 54,235,695. At the end of 2023 the company had 54,235,695 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Cara Therapeutics from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 54.23 M | 0.88% |
| 2022 | 53.76 M | 1.9% |
| 2021 | 52.75 M | 12.52% |
| 2020 | 46.88 M | 0.42% |
| 2019 | 46.69 M | 18.38% |
| 2018 | 39.44 M | 20.85% |
| 2017 | 32.63 M | 19.59% |
| 2016 | 27.29 M | 0.18% |
| 2015 | 27.24 M | 19.52% |
| 2014 | 22.79 M | 4.34% |
| 2013 | 21.84 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 4,338.41% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 10,311.96% | 🇺🇸 USA |
 Trevena TRVN | 13,964,301 | -74.25% | 🇺🇸 USA |
 Recro Pharma
REPH | 23,565,700 | -56.55% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | 38,562,800 | -28.90% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 1,242,000 | -97.71% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | 16,758,322 | -69.10% | 🇺🇸 USA |